Jun 29, 2025, 13:46
Molecular Upgrade: 2025 Hemophilia Care Hits Next Level
William McKeown recently posted on X:
”Beautiful slide from Maria Elisa Mancuso summarising the molecules which can be used to treat Hemophilia at the European Haemophilia Consortium Leadership Conference.”
Haemophilia management is advancing so rapidly, it’s as if the disease is preparing for early retirement!
The EHC Leadership Conference is in full swing.
From antibodies to gene therapy, Maria Elisa Mancuso took the stage to present an exciting spectrum of treatment strategies set for 2025.
More updates on Hemophilia with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch